The Chemours Company (NYSE:CC) Q4 2022 Earnings Conference Call February 10, 2023 8:00 AM ET

Company Participants

Jonathan Lock - Senior Vice President and Chief Development Officer

Mark Newman - President and Chief Executive Officer

Sameer Ralhan - Senior Vice President and Chief Financial Officer

Conference Call Participants

Duffy Fischer - Goldman Sachs

Arun Viswanathan - RBC Capital Markets

John McNulty - BMO Capital Markets

Matthew DeYoe - Bank of America Securities

Josh Spector - UBS

Hassan Ahmed - Alembic Global Advisors

Vincent Andrews - Morgan Stanley

John Roberts - Credit Suisse

Operator

Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to The Chemours Company Fourth Quarter and Full Year 2022 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions].

Thank you. Jonathan Lock, Senior Vice President and Chief Development Officer, you may begin your conference.

Jonathan Lock

Hi. Good morning, everybody, and welcome to The Chemours Company's fourth quarter and full-year 2022 earnings conference call. I'm joined today by Mark Newman, President and Chief Executive Officer, and Sameer Ralhan, Senior Vice President and Chief Financial Officer.

Before we start, I'd like to remind you that comments made on this call as well as in the supplemental information provided in our presentation and on our website contains forward-looking statements that involve risks and uncertainties, as described in Chemours' SEC filings. These forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events that may not be realized. Actual results may differ, and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information.

During the course of this call, management will refer to certain non-GAAP financial measures that we believe are useful to investors evaluating the company's performance. A reconciliation of non-GAAP terms and adjustments are included in our release and at the end of our presentation. As a reminder, our prepared remarks, a full transcript and an audio recording, plus our earning deck, has been posted to our website alongside our earnings release. This morning's call will focus purely on Q&A.

With that, I'll turn the call over to our CEO, Mark Newman. Mark?

Mark Newman

Thank you, Jonathan, and thank you all for joining us this morning. I'd like to start this morning by first thanking our Chemours employees, the entire 6,600 strong Team Chemours for another great year, a year of improved results in revenue and earnings and high free cash flow conversion, a year in which we set several records, especially as we think of our TSS and APM businesses.